Metabolic effects of vasoactive agents.
After adequate volume resuscitation, the mainstay of therapy in critically ill patients with shock is treatment with vasoactive substances to restore haemodynamics or to improve regional perfusion. These agents include adrenoceptor agonists with inotropic combined with either vasoconstricting or vasodilating effects, and predominantly vasodilating drugs such as prostacyclin and related compounds. However, vasoactive agents not only affect the cardiovascular system, but also have profound metabolic effects. The interdependence of vasoactive drugs with metabolism may be relevant regarding adequate oxygen and substrate delivery to cover actual organ needs. Therefore, the profiles of these metabolic effects have to be considered during their therapeutic administration.
Träger
K
K
Department of Postoperative Intensive Care Medicine, Clinic for Anaesthesiology, University Medical School, D-89070 Ulm, Germany.
Radermacher
P
P
Debacker
D
D
Vogt
J
J
Jakob
S
S
Ensinger
H
H